![](http://cdn.i.haymarketmedia.asia/?n=finance-asia%2fcontent%2fshutterstock_1896709708.jpg&h=410&w=728&q=75&v=e322934bf3&c=1)
Deals ramp up in Asia’s healthcare space with cancer focus
An acquisition in Hong Kong by the New Frontier Group, an IPO by Sunho Biologics on the HKEX and a $1.5bn investment into Singapore by AstraZeneca, are signs that investments in next generation cancer treatments are increasing in the region.
May 28, 2024